Technology
Health
Pharmaceutical

Collegium Pharmaceutical

$11.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (1.20%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell COLL and other stocks, options, ETFs, and crypto commission-free!

About

Collegium Pharmaceutical, Inc. operates as a pharmaceutical company, which engages in the developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR. Read More The Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy. The Nucynta is a release formulation of tapentadol indicated for the management of acute pain severe enough to require an opioid analgesic. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Stoughton, MA.

Employees
266
Headquarters
Stoughton, Massachusetts
Founded
2003
Market Cap
389.60M
Price-Earnings Ratio
β€”
Dividend Yield
0.00
Average Volume
458.86K
High Today
$11.84
Low Today
$11.33
Open Price
$11.55
Volume
175.05K
52 Week High
$28.91
52 Week Low
$11.33

Collections

Technology
Health
Pharmaceutical
2015 IPO
US
North America

News

Yahoo FinanceMay 11

Edited Transcript of COLL earnings conference call or presentation 8-May-19 8:30pm GMT

Q1 2019 Collegium Pharmaceutical Inc Earnings Call Canton May 11, 2019 (Thomson StreetEvents) -- Edited Transcript of Collegium Pharmaceutical Inc earnings conference call or presentation Wednesday, May 8, 2019 at 8:30:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Alex Dasalla Collegium Pharmaceutical, Inc. - Head of IR * Jos...

70
Yahoo FinanceMay 9

Were Hedge Funds Right About Dumping Collegium Pharmaceutical Inc ?

At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.

92
NasdaqMay 8

Collegium Reports First Quarter 2019 Financial Results

91

Earnings

-$0.74
-$0.54
-$0.35
-$0.15
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
β€”
Actual
Expected Aug 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.